InvestorsHub Logo
Post# of 252488
Next 10
Followers 31
Posts 3757
Boards Moderated 0
Alias Born 01/29/2012

Re: DewDiligence post# 218049

Thursday, 03/22/2018 11:36:33 AM

Thursday, March 22, 2018 11:36:33 AM

Post# of 252488
AbbVie paid Stemcentrx $5.8B in cash ($10B with milestones) to get Rova-T. What a blunder.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.